CD276 and head and neck squamous cell carcinoma: CD276 was highly expressed on the surface of HNSCC and acted as an immune checkpoint to enable cancer stem cells to evade the surveillance of the immune system, while blocking CD276 can effectively enhance T-cell-mediated anti-tumor immunity (Wang et al., 2021b).